Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer

被引:3
作者
Zhu, Ying [1 ,2 ,3 ]
Liu, Zhixian [2 ,3 ,4 ]
Gui, Liang [1 ,2 ,3 ]
Yun, Wen [1 ,2 ,3 ]
Mao, Changfei [1 ,2 ,3 ]
Deng, Rong [1 ,2 ,3 ]
Yao, Yufeng [1 ,2 ,3 ]
Yu, Qiao [1 ,2 ,3 ]
Feng, Jifeng [1 ,2 ,3 ]
Ma, Hongxia [5 ]
Bao, Wei [6 ]
机构
[1] Nanjing Med Univ, Dept Gen Surg, Jiangsu Canc Hosp, Nanjing, Peoples R China
[2] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Peoples R China
[3] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Peoples R China
[4] Nanjing Med Univ, Dept Pharm, Jiangsu Canc Hosp, Nanjing, Peoples R China
[5] Nanjing Med Univ, Dept Epidemiol, Ctr Global Hlth, Sch Publ Hlth,Jiangsu Key Lab Canc Biomarkers Prev, Nanjing, Peoples R China
[6] Nanjing Univ, Jinling Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing, Peoples R China
基金
中国博士后科学基金;
关键词
HOMOLOGOUS RECOMBINATION; DNA-REPAIR; HEPATOCELLULAR-CARCINOMA; SYNTHETICALLY LETHAL; RAD52; INACTIVATION; BRCA MUTATION; DEFICIENCY; POLY(ADP-RIBOSE); MORTALITY; MECHANISM;
D O I
10.1038/s41523-023-00540-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Poly(ADP-ribose) polymerase inhibitors (PARPis) induce DNA lesions that preferentially kill homologous recombination (HR)-deficient breast cancers induced by BRCA mutations, which exhibit a low incidence in breast cancer, thereby limiting the benefits of PARPis. Additionally, breast cancer cells, particularly triple-negative breast cancer (TNBC) cells, exhibit HR and PARPi resistance. Therefore, targets must be identified for inducing HR deficiency and sensitizing cancer cells to PARPis. Here, we reveal that CXorf56 protein increased HR repair in TNBC cells by interacting with the Ku70 DNA-binding domain, reducing Ku70 recruitment and promoting RPA32, BRCA2, and RAD51 recruitment to sites of DNA damage. Knockdown of CXorf56 protein suppressed HR in TNBC cells, specifically during the S and G2 phases, and increased cell sensitivity to olaparib in vitro and in vivo. Clinically, CXorf56 protein was upregulated in TNBC tissues and associated with aggressive clinicopathological characteristics and poor survival. All these findings indicate that treatment designed to inhibit CXorf56 protein in TNBC combined with PARPis may overcome drug resistance and expand the application of PARPis to patients with non-BRCA mutantion.
引用
收藏
页数:13
相关论文
共 45 条
[1]   Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells [J].
Abbasi, Sanna ;
Schild-Poulter, Caroline .
JOURNAL OF PROTEOME RESEARCH, 2019, 18 (03) :1064-1077
[2]   Prokaryotic homologs of the eukaryotic DNA-end-binding protein Ku, novel domains in the Ku protein and prediction of a prokaryotic double-strand break repair system [J].
Aravind, L ;
Koonin, EV .
GENOME RESEARCH, 2001, 11 (08) :1365-1374
[3]   Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN [J].
Arnoult, Nausica ;
Correia, Adriana ;
Ma, Jiao ;
Merlo, Anna ;
Garcia-Gomez, Sara ;
Maric, Marija ;
Tognetti, Marco ;
Benner, Christopher W. ;
Boulton, Simon J. ;
Saghatelian, Alan ;
Karlseder, Jan .
NATURE, 2017, 549 (7673) :548-+
[4]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690
[5]   53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers [J].
Bouwman, Peter ;
Aly, Amal ;
Escandell, Jose M. ;
Pieterse, Mark ;
Bartkova, Jirina ;
van der Gulden, Hanneke ;
Hiddingh, Sanne ;
Thanasoula, Maria ;
Kulkarni, Atul ;
Yang, Qifeng ;
Haffty, Bruce G. ;
Tommiska, Johanna ;
Blomqvist, Carl ;
Drapkin, Ronny ;
Adams, David J. ;
Nevanlinna, Heli ;
Bartek, Jiri ;
Tarsounas, Madalena ;
Ganesan, Shridar ;
Jonkers, Jos .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) :688-U56
[6]   Targeting DNA Repair in Cancer : Beyond PARP Inhibitors [J].
Brown, Jessica S. ;
O'Carrigan, Brent ;
Jackson, Stephen P. ;
Yap, Timothy A. .
CANCER DISCOVERY, 2017, 7 (01) :20-37
[7]   BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink Repair [J].
Bunting, Samuel F. ;
Callen, Elsa ;
Kozak, Marina L. ;
Kim, Jung Min ;
Wong, Nancy ;
Lopez-Contreras, Andres J. ;
Ludwig, Thomas ;
Baer, Richard ;
Faryabi, Robert B. ;
Malhowski, Amy ;
Chen, Hua-Tang ;
Fernandez-Capetillo, Oscar ;
D'Andrea, Alan ;
Nussenzweig, Andre .
MOLECULAR CELL, 2012, 46 (02) :125-135
[8]   Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination [J].
Celli, Giulia B. ;
Denchi, Eros Lazzerini ;
de Lange, Titia .
NATURE CELL BIOLOGY, 2006, 8 (08) :885-U162
[9]   E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing [J].
Chen, De ;
Wang, Yanjie ;
Lu, Ruixun ;
Jiang, Xiaofeng ;
Chen, Xinhui ;
Meng, Nan ;
Chen, Min ;
Xie, Shan ;
Yan, Guang-Rong .
THERANOSTICS, 2020, 10 (19) :8558-8572
[10]   UBE2A Deficiency Syndrome: Mild to Severe Intellectual Disability Accompanied by Seizures, Absent Speech, Urogenital, and Skin Anomalies in Male Patients [J].
de Leeuw, Nicole ;
Bulk, Saskia ;
Green, Andrew ;
Jaeckle-Santos, Lane ;
Baker, Linda A. ;
Zinn, Andrew R. ;
Kleefstra, Tjitske ;
van der Smagt, Jasper J. ;
Vianne Morgante, Angela Maria ;
de Vries, Bert B. A. ;
van Bokhoven, Hans ;
de Brouwer, Arjan P. M. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (12) :3084-3090